Arthneeti
All Q3 FY25 results →
AD

Aster DM Quality Care Ltd

Q3 FY25Healthcare Services

Aster DM Quality Care Q3 FY25 earnings call: Revenue & Margins

Q3 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹762
Market cap₹73.4K Cr
P/E203.4
Updated23 Aug 2026
Read4 min read

The short version

Hospital & Clinics segment grew over 17% in revenue; mature hospitals showing strong margins. Consolidated margin expected to increase from ~19.5% (9M FY25) to above 21% by FY27.

From Aster DM Quality Care Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Hospital & Clinics segment grew over 17% in revenue; mature hospitals showing strong margins.
  • Karnataka & Maharashtra cluster revenue grew 33% YoY.
  • Kerala cluster revenue grew 8% YoY with occupancy at 74%.
  • Andhra & Telangana cluster revenue grew 16% YoY.
  • Outpatient visits up 11%, inpatient visits up 10% YoY in 9M FY25.
  • Lab business grew 14% YoY in 9M FY25; external business growing 27% YoY.
  • Expect non-Aster lab business growth of 35-40% in coming year.
  • Plans to add ~1,700 beds by FY27, mostly via brownfield expansions.
  • Hospital and clinic segment margins expected to reach 24% by FY27.
  • Consolidated margins aimed to be above 21% by FY27.

2 more points from Aster DM Quality Care Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Aster DM Quality Care Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Capital expenditure totaled INR 238 crores for 9M FY25, with about 65% directed towards capacity expansion.
  • Over the next three years, the company plans to add nearly 1,700 beds, mainly via brownfield expansions to maintain margins.
  • Specific projects include:
  • Women and children block with 150 beds expected operational in H1 FY26.
  • Kasargod hospital with 260 beds (north Kerala) also expected in H1 FY26.
  • Small brownfield expansion in Ongole with 75 beds.
  • Tower 4 of 100 beds at Aster Medcity commissioned recently.
  • Pipeline of approximately 1,700 beds to expand total capacity to over 6,800 beds by FY27.

2 more points from Aster DM Quality Care Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
1Health X Platform
Rev 1Mar 1
2Chandan Healthca
Rev 1Mar 3
3
Rev 2Mar 2
4
Rev 2Mar 2
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Aster DM Quality Care Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Aster DM Healthcare. However, the following related points provide insight into their growth and expansion plans: - The company plans to add approximately 1,700 beds by FY27, increasing total capacity from 5,128 beds (as of Dec 31, 2024) to over 6,800 beds. - Major brownfield projects are underway at key hospitals: Aster Medcity (~950 beds), Aster CMI (~850 beds), and Aster Whitefield (~500 beds). - Expansion pipeline is progressing steadily with capacity enhancements. - The company is focused on organic and inorganic growth, including a merger under regulatory approval.

2 more points from Aster DM Quality Care Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Aster DM Quality Care Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.2K Cr, net profit ₹154 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Aster DM Quality Care Ltd's management said in earlier quarters

Others in Healthcare Services this season

  • Vimta Labs Ltd (Q3 FY25)

    Q3 FY25 Revenue from Operations: ₹899 Mn . Key concall takeaways from Vimta Labs Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • 3B Blackbio (Q3 FY25)

    Consolidated Revenue from Operations Q3 FY 2024-25: ₹2,539.25 Lakh vs ₹1,766.89 Lakh in Q3 FY 2023-24 (↑ approx. Key concall takeaways from 3B Blackbio DX…

  • Rainbow Childrens Medicare Ltd (Q3 FY25)

    Mature hospitals show approximately 9% inpatient (IP) volume growth on a like-to-like basis. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

  • Dr Lal Pathlabs (Q3 FY25)

    Swasthfit (bundle test program) continues strong growth (27.2% in Q3 FY25), with plans to expand market penetration beyond Tier-1 and Tier-2 cities. Key…

Compare:vs Apollo Hospitals Enterprise Ltdvs Manipal Health Enterprises Ltdvs Max Healthcare Institute Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Aster DM Quality Care Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Aster DM Quality Care Ltd Q3 FY25 results?

Hospital & Clinics segment grew over 17% in revenue; mature hospitals showing strong margins. Consolidated margin expected to increase from ~19.5% (9M FY25) to above 21% by FY27.

What is Aster DM Quality Care Ltd share price analysis?

Aster DM Quality Care Ltd currently shows a neutral. The stock trades at a P/E of 203.4 with a market cap of ₹73,404 Cr. Investors should review the full earnings analysis for detailed insights.

Is Aster DM Quality Care Ltd planning capital expenditure?

Capital expenditure totaled INR 238 crores for 9M FY25, with about 65% directed towards capacity expansion.

Keep Aster DM Quality Care Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.